Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
André J. Scheen. (2021) Careful use to minimize adverse events of oral antidiabetic medications in the elderly. Expert Opinion on Pharmacotherapy 22:16, pages 2149-2165.
Read now
Read now
Frank Lavernia & Lawrence Blonde. (2020) Clinical review of the efficacy and safety of oral semaglutide in patients with type 2 diabetes compared with other oral antihyperglycemic agents and placebo. Postgraduate Medicine 132:sup2, pages 15-25.
Read now
Read now
Stephen A. Brunton, Ofri Mosenzon & Eugene E. Wright Jr. (2020) Integrating oral semaglutide into clinical practice in primary care: for whom, when, and how?. Postgraduate Medicine 132:sup2, pages 48-60.
Read now
Read now
Eugene E. Wright Jr & Vanita R. Aroda. (2020) Clinical review of the efficacy and safety of oral semaglutide in patients with type 2 diabetes considered for injectable GLP-1 receptor agonist therapy or currently on insulin therapy. Postgraduate Medicine 132:sup2, pages 26-36.
Read now
Read now
Articles from other publishers (7)
Yi Liu, Wanmu Xie, Yue Yan, Baoyi Liu, Ang Li, Yue Yang, Xinzhu Zhou, Xianbo Zuo, Zhenguo Zhai & Yong Cui. (2024) Study on the mechanism of Cutaneous and Respiratory Comorbidities with Chinese and Western medicine theories and research. Advanced Chinese Medicine.
Crossref
Crossref
Miodrag Janić, Marija Jovanović, Andrej Janež & Mojca Lunder. (2023) Efficacy, safety, and patient satisfaction with oral semaglutide: first single-centre clinical experience. Journal of International Medical Research 51:11.
Crossref
Crossref
Edoardo Mannucci & Daniele Scoccimarro. 2023. Optimizing Pharmacotherapy in Older Patients. Optimizing Pharmacotherapy in Older Patients
331
347
.
Yamin Shu, Xucheng He, Pan Wu, Yanxin Liu, Yufeng Ding & Qilin Zhang. (2022) Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system. Frontiers in Public Health 10.
Crossref
Crossref
Zhihua Ren, Samuel Kumi Okyere, Lei Xie, Juan Wen, Jiayi Wang, Zhengli Chen, Xueqin Ni, Junliang Deng & Yanchun Hu. (2022) Oral Administration of Bacillus toyonensis Strain SAU-20 Improves Insulin Resistance and Ameliorates Hepatic Steatosis in Type 2 Diabetic Mice. Frontiers in Immunology 13.
Crossref
Crossref
Wei Peng, Rui Zhou, Ze-Fang Sun, Jia-Wei Long & Yong-Qiang Gong. (2022) Novel Insights into the Roles and Mechanisms of GLP-1 Receptor Agonists against Aging-Related Diseases. Aging and disease 13:2, pages 468.
Crossref
Crossref
Cláudia Azevedo, Soraia Pinto, Sopisa Benjakul, Jeannette Nilsen, Hélder A. Santos, Giovanni Traverso, Jan Terje Andersen & Bruno Sarmento. (2021) Prevention of diabetes-associated fibrosis: Strategies in FcRn-targeted nanosystems for oral drug delivery. Advanced Drug Delivery Reviews 175, pages 113778.
Crossref
Crossref